News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
202,894 Results
Type
Article (4697)
Company Profile (94)
Press Release (198103)
Section
Business (62917)
Career Advice (95)
Deals (11931)
Drug Delivery (7)
Drug Development (34421)
Employer Resources (12)
FDA (3870)
Job Trends (3783)
News (113061)
Policy (8385)
Tag
Academia (217)
Alliances (16718)
Alzheimer's disease (371)
Approvals (3893)
Bankruptcy (55)
Best Places to Work (3230)
Biotechnology (67)
Breast cancer (51)
Cancer (521)
Career advice (87)
CAR-T (31)
Cell therapy (85)
Clinical research (29288)
Collaboration (200)
Compensation (179)
COVID-19 (486)
C-suite (58)
Data (603)
Diabetes (52)
Diagnostics (877)
Drug discovery (30)
Earnings (26087)
Events (35734)
Executive appointments (210)
FDA (4143)
Funding (148)
Gene therapy (34)
GLP-1 (148)
Government (575)
Healthcare (2594)
Infectious disease (506)
Inflammatory bowel disease (41)
IPO (6290)
Job creations (711)
Job search strategy (82)
Layoffs (36)
Legal (1511)
Lung cancer (88)
Lymphoma (40)
Manufacturing (72)
Medical device (1349)
Medtech (1350)
Mergers & acquisitions (5822)
Metabolic disorders (148)
Neuroscience (493)
NextGen: Class of 2025 (881)
Non-profit (233)
Northern California (808)
Obesity (67)
Parkinson's disease (35)
Patents (38)
People (18180)
Pharmaceutical (34)
Phase I (8547)
Phase II (13138)
Phase III (9806)
Pipeline (269)
Postmarket research (673)
Preclinical (3125)
Radiopharmaceuticals (105)
Rare diseases (74)
Real estate (1403)
Regulatory (6745)
Research institute (259)
Schizophrenia (33)
Southern California (655)
Startups (1018)
United States (6165)
Vaccines (86)
Date
Today (66)
Last 7 days (215)
Last 30 days (977)
Last 365 days (12779)
2025 (1035)
2024 (12960)
2023 (14923)
2022 (19539)
2021 (20761)
2020 (18114)
2019 (11634)
2018 (8461)
2017 (10548)
2016 (8925)
2015 (11495)
2014 (8723)
2013 (6635)
2012 (6715)
2011 (6795)
2010 (6656)
Location
Africa (135)
Asia (26917)
Australia (3363)
California (1703)
Canada (506)
China (249)
Colorado (48)
Connecticut (63)
Delaware (55)
Europe (30559)
Florida (192)
Georgia (50)
Illinois (74)
Indiana (44)
Japan (74)
Kansas (52)
Maryland (194)
Massachusetts (1380)
Minnesota (81)
New Jersey (653)
New York (613)
North Carolina (286)
Northern California (808)
Ohio (45)
Pennsylvania (299)
South America (198)
Southern California (655)
Texas (166)
Utah (34)
Virginia (44)
Washington State (84)
202,894 Results for "intas biopharmaceuticals ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Coherus Announces Agreement to Divest UDENYCA® Franchise for up to $558 million to Intas Pharmaceuticals Ltd.
December 3, 2024
·
15 min read
Press Releases
Accord BioPharma Announces Agreement by Intas Pharmaceuticals, Ltd. to Acquire UDENYCA® (pegfilgrastim-cbqv) Business from Coherus BioSciences, Inc., Unlocking Potential for Continued U.S. Growth
December 3, 2024
·
8 min read
Press Releases
Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044
January 2, 2025
·
2 min read
Business
Henlius Deepens Collaboration with Intas to bring Henlius’ Novel anti-PD-1 mAb Serplulimab to Europe and India
Shanghai Henlius Biotech, Inc. (2696.HK) has entered into an exclusive license agreement with Intas Pharmaceuticals Limited (“Intas”) for the development and commercialisation in Europe and India for several indications including ES-SCLC, and specific formulation of HANSIZHUANG (serplulimab injection), Henlius’ novel anti-PD-1 mAb.
October 27, 2023
·
10 min read
Business
Mid-Atlantic BioTherapeutics, Inc. and SMITM Capital Markets Ltd enter into a significant financing agreement
SMITM CAPITAL MARKETS LTD, has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT), a clinical-stage ready US biopharmaceutical company.
June 19, 2024
·
4 min read
Policy
Cancer Drug Manufacturer Intas Slapped with FDA Warning Letter
Following reports of destroyed and discarded data, the U.S. regulator issued a warning letter to India’s Intas Pharmaceuticals regarding violations of current good manufacturing practice.
August 2, 2023
·
2 min read
·
Tristan Manalac
Press Releases
BlackfinBio Ltd announces the acquisition of Parkinson’s IP patent portfolio from OXB
January 8, 2025
·
1 min read
Press Releases
WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
November 28, 2024
·
4 min read
Press Releases
AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.
December 24, 2024
·
8 min read
Press Releases
AI/ML Innovations to Acquire Quantum Sciences Ltd
December 10, 2024
·
4 min read
1 of 20,290
Next
